BiomX (PHGE) Interest & Investment Income (2018 - 2022)
BiomX (PHGE) posted Interest & Investment Income of $280000.0 for Q3 2022, down 17.4% sequentially from $339000.0 in Q2 2022, and up 1850.0% YoY from $14359.0 in Q3 2021.
BiomX (PHGE) Interest & Investment Income (2018 - 2022) Analysis & Trends
BiomX has reported Interest & Investment Income for 5 years, with the latest figure at $280000.0 in Q3 2022.
- Quarterly Interest & Investment Income rose 1850.0% year-over-year to $280000.0 in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $612000.0 (up 2960.0% YoY) and the FY2021 annual result came in at $2000.0, down 98.84% from the prior year.
- Interest & Investment Income eased to $280000.0 in Q3 2022 per PHGE's latest filing, from $339000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $1.2 million in Q3 2019 and troughed at -$94000.0 in Q4 2021.
- A 5-year average of $225497.3 and a median of $87000.0 in 2022 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2021 and 2022: Interest & Investment Income plunged 220.0% in 2021, then surged 1850.0% in 2022.
- Over 5 years, Interest & Investment Income stood at $34459.0 in 2018, then jumped by 3330.16% to $1.2 million in 2019, then plunged by 106.43% to -$76000.0 in 2020, then retreated by 23.68% to -$94000.0 in 2021, then jumped by 397.87% to $280000.0 in 2022.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $280000.0, $339000.0, and $87000.0 for Q3 2022, Q2 2022, and Q1 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | BiomX | 351,774.34 | -816,225.66 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 280,000.00 |
| Jun 30, 2022 | 339,000.00 |
| Mar 31, 2022 | 87,000.00 |
| Dec 31, 2021 | -94,000.00 |
| Sep 30, 2021 | -16,000.00 |
| Jun 30, 2021 | -31,000.00 |
| Mar 31, 2021 | 143,000.00 |
| Dec 31, 2020 | -76,000.00 |
| Sep 30, 2020 | -5,000.00 |
| Jun 30, 2020 | 188,000.00 |
| Mar 31, 2020 | 65,000.00 |
| Sep 30, 2019 | 1.18 Mn |
| Jun 30, 2019 | 787,000.00 |
| Mar 31, 2019 | 499,000.00 |
| Dec 31, 2018 | 34,459.00 |